Moreover, Brooks et al. treated phenylketonuria (PKU) mice with an ionizable lipid SM-102-based LNP encapsulating adenine base editors (ABEs) mRNA and sgRNA targeting pathogenic variants of the phenylalanine hydroxylase (PAH) gene by retro-orbital injection. The gene discussed is PAH; the disease is phenylketonuria.